Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 771-780

  Cherepanov, Peter ^a   Esté, José A ^a   Rando, Robert F ^c   Ojwang, Joshua O ^c   Reekmans, Gunther ^b   Steinfeld, Robert ^b   David, Guido ^b   De Clercq, Erik ^a   Debyser, Zeger ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Antigenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; DS 5000; GUANOSINE DERIVATIVE; INTEGRASE; ISIS 5320; OLIGONUCLEOTIDE; T 30677; T 30695; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME; ZINTEVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG MECHANISM; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS RESISTANCE;

EID: 0030832691     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.771     Document Type: Article

References (36)

1. De Clercq, E. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J. Med. Chem. 38:2491-2517 (1995).
2. LaFemina, R. L., C. L. Schneider, H. L. Robbins, P. L. Callahan, K. LeGrow, E. Roth, W. A. Schleif, and E. A. Emini. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66:7414-7419 (1992).
3. Sakai, H., M. Kawamura, J. Sakugari, S. Sakugari, R. Shibata, A. Ishimoto, N. Ono, S. Ueda, and A. Adachi. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67: 1169-1174 (1993).
4. Vink, C., M. Banks, R. Bethell, and R. H. A. Plasterk. A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein. Nucleic Acids Res. 22:2176-2177 (1994).
5. Hazuda, D. J., J. C. Hastings, A. L Wolfe, and E. A. Emini. A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res. 22:1121-1122 (1994).
6. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science (Washington D. C.) 266:1981-1986 (1994).
7. Katz, R. A., and A. M. Skalka. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173 (1994).
8. Bushman, F. D., and R. Craigie. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88:1339-1343 (1991).
9. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (Washington D. C.) 255:723-726 (1992).
10. Lodi, P. J., J. A. Ernst, J. Kuszewski, A. B. Hickman, A. Engelman, R. Craigie, G. M. Clore, and A. M. Groncnborn. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34:9826-9833 (1995).
11. Ejkelenboom, A. P. A. M., R. A. Puras Lutzke, R. Boelens, R. H. A. Plasterk, R. Kaptein, and K. Hard. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nature Struct. Biol. 2:807-810 (1995).
12. Van Gent, D. C., C. Vink, A. A. M. Oude Groeneger, and R. H. A. Plasterk. Complementation between HIV integrase proteins mutated in different domains. EMBO J. 12:3261-3267 (1993).
13. Engelman, A., F. D. Bushman, and R. Craigie. Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J. 12:3269-3275 (1993).
14. Puras Lutzke, R. A., N. Eppens, P. Weber, R. A. Houghten, and R. H. A. Plasterk. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc. Natl. Acad. Sci. USA 92:11456-11460 (1995).
15. Fesen, M. R., Y. Pommier, F. Leteurtre, S. Hirogushi, J. Yung, and K. Kohn. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608 (1994).
16. Ojwang, J. O., R. W. Buckheit, Y. Pommier, A. Mazumder, K. De Vreese, J. Esté, D. Reymen, L. A. Pallansch, C. Lackman-Smith, T. L. Wallace, E. De Clercq, M. S. McGrath, and R. F. Rando. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 39:2426-2435 (1995).
17. Mouscadet, J.-F., S. Carteau, H. Goulaouic, F. Subra, and C. Auclair. Triplex-mediated inhibition of HIV DNA integration in vitro. J. Biol. Chem. 269:21635-21638 (1994).
18. Fesen, M. R., K. W. Kohn, F. Leteurtre, and Y. Pommier. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. USA 90:2399-2403 (1993).
19. Robinson, W. E., M. G. Reiecke, S. Abdel-Malek, Q. Jia, and S. A. Chow. Inhibitors of HIV replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93:6326-6331 (1996).
20. Mazumder, A.,D. Cooney, R. Agbaria, M. Gupta, and Y. Pommier. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidilate. Proc. Natl. Acad. Sci. USA 91:5771-5775 (1994).
21. Mazumder, A., N. Neamati, J.-P. Sommadossi, G. Gosselin, R. F. Schinazi, J.-L. Imbach, and Y. Pommier. Effects of nucleotide analogs on human immunodeficiency virus integrase. Mol. Pharmacol. 49:621-628 (1996).
22. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337 (1986).
23. Wyatt, J. R., T. A. Vickers, J. L. Roberson, R. W. Buckheit, T. Klimkait, E. DeBaets, P. W. Davis, B. Rayner, J. L. Imbach, and D. J. Ecker. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA 91:1356-1360 (1994).
24. Rando, R. F., J. Ojwang, A. Elbaggari, G. R. Reyes, R. Tinder, M. S. McGrath, and M. E. Hogan. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J. Biol. Chem. 270:1754-1760 (1995).
25. Bishop, J. S., J. K. Guy-Caffey, J. O. Ojwang, S. R. Smith, M. E. Hogan, P. A. Cossum, R. F. Rando, and N. Chaudhary. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J. Biol. Chem. 271:5698-5703 (1996).
26. Buckheit, R. W., J. L. Roberson, C. Lackman-Smith, J. R. Wyatt, T. A. Vickers, and D. J. Ecker. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res. Hum. Retroviruses 10:1497-1506 (1994).
27. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. Correct integration of retroviral DNA in vitro. Cell 49:347-356 (1987).
28. Vink, C., K. H. van der Linden, and R. H. A. Plasterk. Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J. Virol. 68:1468-1474 (1994).
29. Ellison, V., and P. O. Brown. A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc. Natl. Acad. Sci. USA 91:7316-7320 (1994).
30. Pemberton, I. K., M. Buckle, and H. Buc. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). J. Biol. Chem. 271:1498-1506 (1996).
31. Müller, B., K. S. Jones, G. W. Merkel, and A. M. Skalka. Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. Proc. Natl. Acad. Sci. USA 90:11633-11637 (1993).
32. Lee, S. P., H. G. Kim, M. L. Censullo, and M. K. Han. Substrate-length-dependent activities of human immunodeficiency virus type 1 integrase in vitro: differential DNA binding affinities associated with different lengths of substrates. Biochemistry 34:10205-10214 (1995).
33. Eich, E., H. Pertz, M. Kaloga, J. Schulz, M. Fesen, A. Mazumder, and Y. Pommier. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 39:86-95 (1996).
34. Jing, N., R. F. Rande, Y. Pommier, and M. E. Mogan. Ion-selective folding of loop domains in a potent anti-HIV oligonucleotide. Biochemistry, in press.
35. Mazumder, A., N. Neamati, J. O. Ojwang, S. Sunder, R. F. Rando, and Y. Pommier. Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 35:13762-13771 (1996).
36. Ellison, V., J. Gerton, K. A. Vincent, and P. O. Brown. An essential interaction between distinct domains of HIV-1 integrase mediates assembly of the active multimer. J. Biol. Chem. 270:3320-3326 (1995).